 Endogenous prostaglandin endoperoxides prostacyclin thrombolytic activity tissue plasminogen activator Effects simultaneous inhibition thromboxane synthase blockade thromboxane receptors canine model coronary thrombosis hypothesis simultaneous inhibition synthase blockade receptors effective thrombolysis reocclusion discontinuation tissue plasminogen activator t-PA intervention Coronary thrombosis dogs copper coil left anterior coronary artery Coronary flow Doppler flow probe min thrombus formation animals saline controls mg/kg bolus mg/kg infusion receptor antagonist dazoxiben mg/kg bolus mg/kg infusion synthase inhibitor mg/kg bolus mg/kg infusion drug receptors inhibits synthase dogs heparin U/kg bolus t-PA micrograms/kg continuous infusion micrograms/kg min min reperfusion time SQ dogs controls min NS dazoxiben min controls SQ dogs administration lysis time dazoxiben-treated group Reocclusion control dogs SQ dogs dazoxiben-treated dogs animals alpha blood samples coronary artery distal thrombus reperfusion reocclusion control animals dogs SQ increase plasma levels alpha levels respect SQ dogs simultaneous inhibition synthase blockade receptors effective intervention experimental model thrombolysis reocclusion t-PA administration